A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
Clinical trial NCT06237413 · UNKNOWN
Trial details
- NCT number
- NCT06237413
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2026-02-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.